Reported Results in Preclinical Models Published work reports increased dendritic spine density and synapse number in hippocampal culture, alongside cognitive endpoints in impaired rodent models
Observed Side Effects (From Clinical Trials) In the Lancet 2021 Phase 2 trial (n=706), at the highest 4.5 mg/week dose, 88% of participants reported at least one side effect and 63% reported a GI-specific event
"2-Aminomethylene-5-sulfonylthiazole Inhibitors of Lysyl Oxidase (LOX) and LOXL2 Show Significant Efficacy in Delaying Tumor Growth"
Animal models of Achilles tendon injury show BPC-157 treatment significantly improves recovery as evidenced by biochemical markers and microscopic observations
Now lets embark on a journey towards optimal wellbeing, one conversation at a time
What lipotropic injections plausibly contribute is more modest and more defensible: correction of real deficiencies, a tolerable non-stimulant option for patients who cannot or will not take prescription weight loss medication, and a recurring touchpoint that keeps patients engaged with a supervised program